ANDA 84467, held by Watson Labs. Hydrochlorothiazide; Reserpine.
As of Nov 16, 2026, ANDA 84467 (Hydrochlorothiazide W/ Reserpine), held by Watson Labs, was first approved by FDA on Jan 7, 1977, with 16 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Jan 7, 1977 | Original application | Approved | None posted |
| Product | Active ingredient | Marketing |
|---|---|---|
| Hydrochlorothiazide W/ Reserpine50MG;0.125MG ยท tablet;oral | Hydrochlorothiazide; Reserpine | Discontinued |
| Sep 27, 1994 | Supplement 30Labeling | Approved | None posted |
| Jul 25, 1991 | Supplement 29Labeling | Approved | None posted |
| Nov 19, 1990 | Supplement 28Manufacturing | Approved | None posted |
| Jun 29, 1990 | Supplement 26Manufacturing | Approved | None posted |
| Dec 19, 1989 | Supplement 25Labeling | Approved | None posted |
| Oct 14, 1988 | Supplement 20Labeling | Approved | None posted |
| Jul 21, 1988 | Supplement 23Manufacturing | Approved | None posted |
| Jul 21, 1988 | Supplement 22Manufacturing | Approved | None posted |
| Jul 21, 1988 | Supplement 21Manufacturing | Approved | None posted |
| Jun 17, 1988 | Supplement 24Labeling | Approved | None posted |
| Feb 29, 1984 | Supplement 18Manufacturing | Approved | None posted |
| Apr 25, 1983 | Supplement 16Manufacturing | Approved | None posted |
| Dec 30, 1981 | Supplement 12Manufacturing | Approved | None posted |
| Dec 30, 1981 | Supplement 11Manufacturing | Approved | None posted |
| Dec 30, 1981 | Supplement 10Manufacturing | Approved | None posted |
| Dec 30, 1981 | Supplement 6Manufacturing | Approved | None posted |
| Jan 7, 1977 | Original application | Approved | None posted |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters